VSNL1 and Cognitive impairment: Similarly, several longitudinal studies pointed out that the concentration of VILIP-1 and/or VILIP-1/Aβ42 in CSF could be applied to diagnose diseases at an early stage, and predicted the future cognitive impairment of normal individuals (Luo et al., 2013).